| 000 | 01404 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250515191324.0 | ||
| 264 | 0 | _c20091203 | |
| 008 | 200912s 0 0 eng d | ||
| 022 | _a1873-3468 | ||
| 024 | 7 |
_a10.1016/j.febslet.2009.10.004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChen, P | |
| 245 | 0 | 0 |
_aFull characterization of PDX, a neuroprotectin/protectin D1 isomer, which inhibits blood platelet aggregation. _h[electronic resource] |
| 260 |
_bFEBS letters _cNov 2009 |
||
| 300 |
_a3478-84 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aArachidonate 15-Lipoxygenase _xmetabolism |
| 650 | 0 | 4 |
_aCarbon _xchemistry |
| 650 | 0 | 4 |
_aDocosahexaenoic Acids _xchemistry |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aGas Chromatography-Mass Spectrometry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxides _xchemistry |
| 650 | 0 | 4 | _aMagnetic Resonance Spectroscopy |
| 650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
| 650 | 0 | 4 |
_aGlycine max _xenzymology |
| 650 | 0 | 4 | _aStereoisomerism |
| 700 | 1 | _aFenet, B | |
| 700 | 1 | _aMichaud, S | |
| 700 | 1 | _aTomczyk, N | |
| 700 | 1 | _aVéricel, E | |
| 700 | 1 | _aLagarde, M | |
| 700 | 1 | _aGuichardant, M | |
| 773 | 0 |
_tFEBS letters _gvol. 583 _gno. 21 _gp. 3478-84 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.febslet.2009.10.004 _zAvailable from publisher's website |
| 999 |
_c19212560 _d19212560 |
||